2023.01.30Shonan iPark and the Maryland State Government have formed a partnership alliance to support the creation and development of global startup companies in the life science field
2022.12.21【Press Release】 Shonan iPark Outlines New Operational Structure to Provide Scale and Sustainable Long-Term Growth for the Ecosystem
2022.09.28【Press Release】Shonan iPark Announces Finalists of its Second Incubation Program: “Japan Innovation Bloom GRANT CALL 2022”
2022.07.13【Media Coverage】Toshio Fujimoto, General Manager of Shonan iPark, was interviewed by Sankei Newspaper regarding the creation of an effective drug discovery ecosystem in Japan “Reviving the Pharmaceutical Industry: Overcoming Vaccine Defeat”
2022.05.13【Press Release】Shonan iPark Collaborates with Johnson & Johnson Innovation, Janssen Research & Development, LLC, and Takeda Pharmaceutical Company Limited to Launch Japan Innovation Bloom GRANT CALL 2022
2022.03.24【Press Release】Shonan iPark Signs Memorandum of Understanding for Strategic Alliance with Chinese Science Park ‘Suzhou Industrial Park’
2021.12.01【Press Release】ARTham Therapeutics, Inc. Enters into Share Transfer Agreement with Kaken Pharmaceutical Co., Ltd.
2021.08.10【Tenant’s News】New company “Orizuru Therapeutics Inc.” launched from T-CiRA in Shonan iPark.
2021.06.22【Press Release】iPark Invites Companies to Join Second Phase of “Japan VC Consortium,”a Platform Driving VC, CVC, and Pharmaceutical Company Collaboration
